Search Within

Andrea Cercek Hanjis

  1. "Early Drug Development Service"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (4)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (9)
  2. Department of Medicine (9)
  3. Department of Pathology and Laboratory Medicine (9)
  4. Early Drug Development Service (9)
  5. GSK Faculty (9)
  6. Gastrointestinal Oncology Service (9)

More Groups

People
  1. David Hyman (9)
  2. Leonard Saltz (9)
  3. Michael Berger (9)
  4. David Solit (7)
  5. Jaclyn Hechtman (7)
  6. Anna Varghese (6)

More People

Years
  1. 2018 (5)
  2. 2017 (3)
  3. 2016 (1)
Publications
  1. Journal of Clinical Oncology (4)
  2. Annals of Oncology (1)
  3. Cancer Cell (1)
  4. Cancer Research (1)
  5. Clinical Cancer Research (1)
  6. Nature Medicine (1)
Publishers
  1. American Society of Clinical Oncology (4)
  2. American Association for Cancer Research (2)
  3. Cell Press (1)
  4. Nature Publishing Group (1)
  5. Oxford University Press (1)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic landscape, clinical characteristics and outcomes of early onset (EO) compared with average onset (AO) colorectal cancer (CRC)
    Meeting Abstract

    Dos Santos Fernandes, G.; Chatila, W. K.; Yaeger, R.; Mendelsohn, R. B.; Stadler, Z. K.; Segal, N. H.; Varghese, A. M.; Lagunes, D. R.; Diaz, L. A.; Shia, J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Prevalence of germline genetic alterations in colorectal cancer patients
    Meeting Abstract

    Cercek, A.; Kemel, Y.; Mandelker, D.; Stewart, C.; Arnold, A. G.; Sheehan, M.; Yaeger, R.; Segal, N. H.; Varghese, A. M.; Saltz, L. B.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Comparing metastatic (M) young onset (YO) colorectal cancer (CRC) with average onset (AO): Do they differ clinically and genetically?
    Meeting Abstract

    Dos Santos Fernandes, G.; Chatila, W.; Yaeger, R.; Mendelsohn, R.; Stadler, Z.; Segal, N. H.; Varghese, A.; Reidy, D.; Diaz, L.; Shia, J.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Comprehensive molecular profiling of intrahepatic and extrahepatic cholangiocarcinomas: Potential targets for intervention
    Journal Article

    Lowery, M. A.; Ptashkin, R.; Jordan, E.; Berger, M. F.; Zehir, A.; Capanu, M.; Kemeny, N. E.; O'Reilly, E. M.; El-Dika, I.; Jarnagin, W. R.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Clinical sequencing defines the genomic landscape of metastatic colorectal cancer
    Journal Article

    Yaeger, R.; Chatila, W. K.; Lipsyc, M. D.; Hechtman, J. F.; Cercek, A.; Sanchez-Vega, F.; Jayakumaran, G.; Middha, S.; Zehir, A.; Donoghue, M. T. A.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • A prospective analysis of germline alterations (GA) in biliary tract cancer (BTC)
    Meeting Abstract

    Lowery, M. A.; Jordan, E.; Kemel, Y.; Mukherjee, S.; Cercek, A.; Kemeny, N. E.; Varghese, A. M.; Rusek, M.; Boucher, T. M.; Mandelker, D.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Mechanisms of acquired resistance to BRAF V600E inhibition in colon cancers converge on RAF dimerization and are sensitive to its inhibition
    Journal Article

    Yaeger, R.; Yao, Z.; Hyman, D. M.; Hechtman, J. F.; Vakiani, E.; Zhao, H.; Su, W.; Wang, L.; Joelson, A.; Cercek, A.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
    Journal Article

    Zehir, A.; Benayed, R.; Shah, R. H.; Syed, A.; Middha, S.; Kim, H. R.; Srinivasan, P.; Gao, J.; Chakravarty, D.; Devlin, S. M.; more...
    Nature Medicine (2017)

    Fulltext@MSK | Save
  • Comprehensive molecular profiling and analysis of mutual exclusivity of genetic aberrations (MEGA) of intra- and extrahepatic cholangiocarcinomas (IHC and EHC) evaluation of prognostic features and potential targets for intervention
    Meeting Abstract

    Lowery, M. A.; Ptashkin, R.; Jordan, E.; Berger, M. F.; Zehir, A.; Kemeny, N. E.; O'Reilly, E. M.; Jarnagin, W. R.; Harding, J. J.; DeMatteo, R. P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save